SOD2P1

Across TCGA pan-cancer cohorts, SOD2P1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SOD2P1 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher SOD2P1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated SOD2P1 expression acts as an unfavorable survival marker.

THCA, SKCM, and STAD are the cancer types where SOD2P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.229	0.947	<.001	141	view →
SKCM	OS	Tertile	III,IV	0.174	0.802	<.001	81	view →
STAD	OS	Tertile	All	0.315	0.593	<.001	78	view →
KIRP	DFS	Tertile	II,III,IV	0.040	0.771	<.001	75	view →
UCS	OS	Tertile	II,III,IV	0.202	0.623	.019	72	view →
CESC	OS	Tertile	All	0.146	0.597	.001	48	view →
PAAD	DFS	Tertile	All	0.103	0.509	<.001	36	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
KIRC	DFS	Tertile	IV	0.228	0.509	.030	36	view →
UCEC	DFS	Tertile	All	0.110	0.652	<.001	36	view →
CHOL	DFS	Tertile	All	0.117	0.495	.017	27	view →
SARC	DFS	Tertile	All	0.336	0.618	.007	21	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SOD2P1–THCA (OS)

Open the THCA breakdown →